Literature DB >> 11929471

Principles of nephrectomy for malignant disease.

G H J Mickisch1.   

Abstract

For many years the prevailing belief was to advocate'radical' nephrectomy via a transperitoneal approach as the standard surgical procedure for renal cell carcinoma (RCC). because the early control of the renal vessels before manipulating the kidney should minimize the likelihood of disseminating tumour cells during surgery. This philosophy was based on retrospective data which were never confirmed in a controlled trial. Since then,evidence has accumulated that some patients maybe better served by an extraperitoneal (translumbar)approach, providing similar oncological efficacy with the added advantage of reduced morbidity. However,these results are again either retrospective or statistically insignificant, and therefore do not allow firm conclusions. Nevertheless, if there is any difference in the possible intraoperative dissemination of tumour, depending on the type of surgical approach, it will be small, requiring analysis in a large randomized multicentre trial. The treatment of choice for disease that is not disseminated is surgery, although the 5-year survival rates for all stages do not exceed 60%, even in contemporary series. Further improvements will probably have to rely on the development of more effective systemic therapy and the application of combined treatments to counter the relatively many patients presenting with advanced stages. Concepts and progress in this field appear to be of major interest for modern uro-oncologists after the advent of immunotherapeutic strategies that require a surgical intervention at some stage of the treatment cascade.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11929471     DOI: 10.1046/j.1464-410x.2002.02654.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  12 in total

1.  Neoadjuvant targeted therapy in a primary metastasized renal cell cancer patient leads to down-staging of inferior vena cava thrombus (IVC) enabling a cardiopulmonary bypass-free tumor nephrectomy: a case report.

Authors:  Inga Peters; Michael Winkler; Björn Jüttner; Omke E Teebken; T R Herrmann; Christoph von Klot; Mario Kramer; Angela Reichelt; Mahmoud Abbas; Markus A Kuczyk; Axel S Merseburger
Journal:  World J Urol       Date:  2012-09-30       Impact factor: 4.226

Review 2.  Combination of surgery and immunotherapy in metastatic renal cell carcinoma.

Authors:  Gerald H Mickisch; Roland H Mattes
Journal:  World J Urol       Date:  2005-03-25       Impact factor: 4.226

3.  [Metastasectomy in renal cell cancer after neoadjuvant therapy with multi-tyrosine kinase inhibitors].

Authors:  P Firek; S Richter; J Jaekel; B Brehmer; A Heidenreich
Journal:  Urologe A       Date:  2012-03       Impact factor: 0.639

Review 4.  [Operative treatment of renal cell carcinoma].

Authors:  A Heidenreich
Journal:  Urologe A       Date:  2011-09       Impact factor: 0.639

5.  Chemotherapeutic drugs sensitize human renal cell carcinoma cells to ABT-737 by a mechanism involving the Noxa-dependent inactivation of Mcl-1 or A1.

Authors:  Henry Zall; Arnim Weber; Robert Besch; Niko Zantl; Georg Häcker
Journal:  Mol Cancer       Date:  2010-06-24       Impact factor: 27.401

Review 6.  [Impact of surgery for residual tumors after chemotherapy].

Authors:  J Hess; F vom Dorp; M Becker; H Rübben; C Börgermann
Journal:  Urologe A       Date:  2009-01       Impact factor: 0.639

Review 7.  Preoperative imaging in renal cell cancer.

Authors:  Axel Heidenreich; Vincent Ravery
Journal:  World J Urol       Date:  2004-07-30       Impact factor: 4.226

8.  Role of surgery in advanced/metastatic renal cell carcinoma.

Authors:  Suresh Bhat
Journal:  Indian J Urol       Date:  2010-04

9.  Identification of genes and pathways involved in kidney renal clear cell carcinoma.

Authors:  William Yang; Kenji Yoshigoe; Xiang Qin; Jun S Liu; Jack Y Yang; Andrzej Niemierko; Youping Deng; Yunlong Liu; A Dunker; Zhongxue Chen; Liangjiang Wang; Dong Xu; Hamid R Arabnia; Weida Tong; Mary Yang
Journal:  BMC Bioinformatics       Date:  2014-12-16       Impact factor: 3.169

10.  Identification of prognostic genes in kidney renal clear cell carcinoma by RNA‑seq data analysis.

Authors:  Yanqin Gu; Linfeng Lu; Lingfeng Wu; Hao Chen; Wei Zhu; Yi He
Journal:  Mol Med Rep       Date:  2017-02-13       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.